Clinical Trials Browser

Phase EARLY_PHASE1 × Carcinoma, Hepatocellular × Nivolumab × Clear all

NCT03812562 2024-02-21

Nivolumab and Yttrium-90 in Treating Patients With Liver Cancer Undergoing Surgical Resection

Phase EARLY_PHASE1 Terminated

Gastrointestinal

Carcinoma, Hepatocellular